Log In
Print
BCIQ
Print
Print this Print this
 

Fenoglide (formerly LCP-FenoChol)

  Manage Alerts
Collapse Summary General Information
Company Veloxis Pharmaceuticals A/S
DescriptionSolid solution MeltDose formulation of low-dose fenofibrate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDyslipidemia
Indication DetailsTreat dyslipidemia
Regulatory Designation

Partner

Salix Pharmaceuticals Ltd.; Shore Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today